UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

JAMA oncology, 2017-09, Vol.3 (9), p.1190

2017

Link zum Volltext

Verfügbarkeit prüfen

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing

JNCI : Journal of the National Cancer Institute, 2018-08, Vol.110 (8), p.863-870

2018

Link zum Volltext

Verfügbarkeit prüfen

Somatic TP53 variants frequently confound germ-line testing results

Genetics in medicine, 2018-08, Vol.20 (8), p.809-816

2018

Link zum Volltext

Verfügbarkeit prüfen

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance

American journal of human genetics, 2021-03, Vol.108 (3), p.458-468

2021

Link zum Volltext

Verfügbarkeit prüfen

P396: The need for a longitudinal digital health platform to implement large scale genomic programs

Genetics in Medicine Open, 2023, Vol.1 (1), p.100432, Article 100432

2023

Link zum Volltext

Verfügbarkeit prüfen

Genotype–phenotype associations among panel-based TP53+ subjects

Genetics in medicine, 2019-11, Vol.21 (11), p.2478-2484

2019

Link zum Volltext

Verfügbarkeit prüfen

Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition

Cancer medicine (Malden, MA), 2022-04, Vol.11 (8), p.1745-1752

2022

Link zum Volltext

Verfügbarkeit prüfen

Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer

Npj genomic medicine, 2022-08, Vol.7 (1), p.49-49, Article 49

2022

Link zum Volltext

Verfügbarkeit prüfen

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance

Npj genomic medicine, 2022-06, Vol.7 (1), p.35-35, Article 35

2022

Link zum Volltext

Verfügbarkeit prüfen

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care

Genetics in medicine, 2018-12, Vol.20 (12), p.1515-1521

2018

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and electrochemical evaluation of an amorphous titanium dioxide derived from a solid state precursor

Journal of power sources, 2010-04, Vol.195 (7), p.2064-2068

2010

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Germline Mutations in Polyposis and Colorectal Cancer–Associated Genes in Patients With Multiple Colorectal Polyps

Clinical gastroenterology and hepatology, 2019-09, Vol.17 (10), p.2008-2015.e3

2019

Link zum Volltext

Verfügbarkeit prüfen

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Journal of clinical oncology, 2020-03, Vol.38 (7), p.674-685

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-09-19: Inequitable access to genetic testing leads to missed screening and prevention opportunities for individuals at risk for hereditary breast and ovarian cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-09-19

2022

Link zum Volltext

Verfügbarkeit prüfen

BAP1 tumor predisposition syndrome: Preliminary data from a laboratory-based multigene panel testing cohort

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.490-490

2017

Link zum Volltext

Verfügbarkeit prüfen

Closing the gap: Trends in inconclusive rates on hereditary cancer testing across racial/ethnic groups

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10525-10525

2021

Link zum Volltext

Verfügbarkeit prüfen

EPID-16. HEREDITARY BRAIN TUMORS ARE MORE COMMON THAN YOU THINK: GERMLINE MUTATIONS IN BENIGN AND MALIGNANT PRIMARY BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi72-vi72

2017

Link zum Volltext

Verfügbarkeit prüfen

Increased detection of germline cancer susceptibility mutations subsequent to tumor profiling

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13613-e13613

2018

Link zum Volltext

Verfügbarkeit prüfen

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield

The journal of clinical endocrinology and metabolism, 2022-04, Vol.107 (5), p.e1917-e1923

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-09-03: Pathogenic variants among female breast cancer patients with a subsequent cancer demonstrate preventable cancer burden

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-09-03

2022

Link zum Volltext

Verfügbarkeit prüfen

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

JNCI : Journal of the National Cancer Institute, 2020-12, Vol.112 (12), p.1242-1250

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-08-35: Impact of multigene panel testing on medical management: Preliminary pre- and post-test clinician survey results

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-08-35

2020

Link zum Volltext

Verfügbarkeit prüfen

Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

Molecular genetics and metabolism, 2021-04, Vol.132, p.S54-S55

2021

Link zum Volltext

Verfügbarkeit prüfen

eP075 - Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Molecular genetics and metabolism, 2021-04, Vol.132, p.S51-S52

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 100

Suche als RSS-Feed

Aktive Filter

ThemaMutation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(100)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing

Somatic TP53 variants frequently confound germ-line testing results

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance

P396: The need for a longitudinal digital health platform to implement large scale genomic programs

Genotype–phenotype associations among panel-based TP53+ subjects

Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition

Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care

Synthesis and electrochemical evaluation of an amorphous titanium dioxide derived from a solid state precursor

Prevalence of Germline Mutations in Polyposis and Colorectal Cancer–Associated Genes in Patients With Multiple Colorectal Polyps

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Abstract P2-09-19: Inequitable access to genetic testing leads to missed screening and prevention opportunities for individuals at risk for hereditary breast and ovarian cancer

BAP1 tumor predisposition syndrome: Preliminary data from a laboratory-based multigene panel testing cohort

Closing the gap: Trends in inconclusive rates on hereditary cancer testing across racial/ethnic groups

EPID-16. HEREDITARY BRAIN TUMORS ARE MORE COMMON THAN YOU THINK: GERMLINE MUTATIONS IN BENIGN AND MALIGNANT PRIMARY BRAIN TUMORS

Increased detection of germline cancer susceptibility mutations subsequent to tumor profiling

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield

Abstract P2-09-03: Pathogenic variants among female breast cancer patients with a subsequent cancer demonstrate preventable cancer burden

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

Abstract P6-08-35: Impact of multigene panel testing on medical management: Preliminary pre- and post-test clinician survey results

Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

eP075 - Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Aktive Filter

Suchergebnisse filtern